Globus Medical (GMED) Stock Forecast & Price Target

Compare

929 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GMED Analyst Ratings

Moderate Buy

9 Buy

4 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Globus

Medical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GMED Stock 12 Month Forecast

Average Price Target

$97.64

▲(12.15% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Globus Medical in the last 3 months. The average price target is $97.64 with a high forecast of $114.00 and a low forecast of $64.00. The average price target represents a 12.15% change from the last price of $87.06.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"$51","67":"$67","83":"$83","99":"$99","115":"$115"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$114.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.64,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$97.64</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$64.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[51,67,83,99,115],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.79,91.6523076923077,93.5146153846154,95.37692307692308,97.23923076923077,99.10153846153847,100.96384615384616,102.82615384615384,104.68846153846154,106.55076923076923,108.41307692307693,110.27538461538461,112.1376923076923,{"y":114,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.79,90.39384615384616,90.99769230769232,91.60153846153847,92.20538461538462,92.80923076923078,93.41307692307693,94.01692307692308,94.62076923076923,95.22461538461539,95.82846153846154,96.43230769230769,97.03615384615385,{"y":97.64,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.79,87.80615384615385,85.8223076923077,83.83846153846154,81.85461538461539,79.87076923076924,77.88692307692308,75.90307692307692,73.91923076923078,71.93538461538462,69.95153846153846,67.96769230769232,65.98384615384616,{"y":64,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":83.9,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.71,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.72,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.11,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.64,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.66,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.39,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$114.00

Average Price Target$97.64

Lowest Price Target$64.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Caitlin Cronin

Canaccord Genuity

$90→$105

Buy

20.61%

Upside

Reiterated

12/17/25

Globus Medical price target raised to $105 from $90 at CanaccordGlobus Medical price target raised to $105 from $90 at Canaccord

Shagun Singh Chadha

RBC Capital

$92→$100

Buy

14.86%

Upside

Reiterated

12/17/25

Globus Medical price target raised to $100 from $92 at RBC CapitalGlobus Medical price target raised to $100 from $92 at RBC Capital

Keith Hinton

Freedom Capital Markets

$87

Hold

-0.07%

Downside

Initiated

12/16/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)

Vik Chopra

Wells Fargo

$79→$98

Buy

12.57%

Upside

Reiterated

12/12/25

Wells Fargo Keeps Their Buy Rating on Globus Medical (GMED)

Travis Steed

Bank of America Securities

$91→$106

Buy

21.76%

Upside

Reiterated

12/08/25

Bank of America Securities Keeps Their Buy Rating on Globus Medical (GMED)

Patrick Wood

Morgan Stanley

$70→$100

Buy

14.86%

Upside

Reiterated

12/02/25

Globus Medical price target raised to $100 from $70 at Morgan StanleyGlobus Medical price target raised to $100 from $70 at Morgan Stanley

Matthew Taylor

Jefferies

$105

Buy

20.61%

Upside

Reiterated

11/24/25

Jefferies Reaffirms Their Buy Rating on Globus Medical (GMED)

Richard Newitter

Truist Financial

$93→$105

Buy

20.61%

Upside

Reiterated

11/18/25

Globus Medical (GMED) Gets a Buy from Truist Financial

Matt Miksic

Barclays

$106→$114

Buy

30.94%

Upside

Reiterated

11/07/25

Globus Medical (GMED) Gets a Buy from Barclays

David Saxon

Needham

Hold

―

Reiterated

11/07/25

Cautious Optimism: Hold Rating for Globus Medical Amid Strong Performance and Revenue Concerns

Ryan Zimmerman

BTIG

Hold

―

Reiterated

11/07/25

Globus Medical: Strong Q3 Performance and Raised Guidance, But Long-term Growth Concerns Justify Hold Rating

Matthew O'Brien

Piper Sandler

$80→$90

Buy

3.38%

Upside

Reiterated

11/07/25

Globus Medical price target raised to $90 from $80 at Piper SandlerGlobus Medical price target raised to $90 from $80 at Piper Sandler

Thomas Stephan

Stifel Nicolaus

$64

Hold

-26.49%

Downside

Initiated

10/28/25

Globus Medical resumed with a Hold at StifelGlobus Medical resumed with a Hold at Stifel

David Turkaly

Citizens JMP

Hold

―

Reiterated

08/20/25

Citizens JMP Remains a Hold on Globus Medical (GMED)

Jason Wittes

Roth MKM

$105

Buy

20.61%

Upside

Reiterated

08/08/25

Roth MKM Reaffirms Their Buy Rating on Globus Medical (GMED)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Caitlin Cronin

Canaccord Genuity

$90→$105

Buy

20.61%

Upside

Reiterated

12/17/25

Globus Medical price target raised to $105 from $90 at CanaccordGlobus Medical price target raised to $105 from $90 at Canaccord

Shagun Singh Chadha

RBC Capital

$92→$100

Buy

14.86%

Upside

Reiterated

12/17/25

Globus Medical price target raised to $100 from $92 at RBC CapitalGlobus Medical price target raised to $100 from $92 at RBC Capital

Keith Hinton

Freedom Capital Markets

$87

Hold

-0.07%

Downside

Initiated

12/16/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)

Vik Chopra

Wells Fargo

$79→$98

Buy

12.57%

Upside

Reiterated

12/12/25

Wells Fargo Keeps Their Buy Rating on Globus Medical (GMED)

Travis Steed

Bank of America Securities

$91→$106

Buy

21.76%

Upside

Reiterated

12/08/25

Bank of America Securities Keeps Their Buy Rating on Globus Medical (GMED)

Patrick Wood

Morgan Stanley

$70→$100

Buy

14.86%

Upside

Reiterated

12/02/25

Globus Medical price target raised to $100 from $70 at Morgan StanleyGlobus Medical price target raised to $100 from $70 at Morgan Stanley

Matthew Taylor

Jefferies

$105

Buy

20.61%

Upside

Reiterated

11/24/25

Jefferies Reaffirms Their Buy Rating on Globus Medical (GMED)

Richard Newitter

Truist Financial

$93→$105

Buy

20.61%

Upside

Reiterated

11/18/25

Globus Medical (GMED) Gets a Buy from Truist Financial

Matt Miksic

Barclays

$106→$114

Buy

30.94%

Upside

Reiterated

11/07/25

Globus Medical (GMED) Gets a Buy from Barclays

David Saxon

Needham

Hold

―

Reiterated

11/07/25

Cautious Optimism: Hold Rating for Globus Medical Amid Strong Performance and Revenue Concerns

Ryan Zimmerman

BTIG

Hold

―

Reiterated

11/07/25

Globus Medical: Strong Q3 Performance and Raised Guidance, But Long-term Growth Concerns Justify Hold Rating

Matthew O'Brien

Piper Sandler

$80→$90

Buy

3.38%

Upside

Reiterated

11/07/25

Globus Medical price target raised to $90 from $80 at Piper SandlerGlobus Medical price target raised to $90 from $80 at Piper Sandler

Thomas Stephan

Stifel Nicolaus

$64

Hold

-26.49%

Downside

Initiated

10/28/25

Globus Medical resumed with a Hold at StifelGlobus Medical resumed with a Hold at Stifel

David Turkaly

Citizens JMP

Hold

―

Reiterated

08/20/25

Citizens JMP Remains a Hold on Globus Medical (GMED)

Jason Wittes

Roth MKM

$105

Buy

20.61%

Upside

Reiterated

08/08/25

Roth MKM Reaffirms Their Buy Rating on Globus Medical (GMED)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Globus Medical

1 Month

xxx

Success Rate

11/17 ratings generated profit

Average Return

+1.37%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 64.71% of your transactions generating a profit, with an average return of +1.37% per trade.

3 Months

xxx

Success Rate

15/23 ratings generated profit

Average Return

+4.55%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +4.55% per trade.

1 Year

Matt MiksicBarclays

Success Rate

21/31 ratings generated profit

Average Return

+17.42%

reiterated a buy rating last month

Copying Matt Miksic's trades and holding each position for 1 Year would result in 67.74% of your transactions generating a profit, with an average return of +17.42% per trade.

2 Years

xxx

Success Rate

28/31 ratings generated profit

Average Return

+35.06%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 90.32% of your transactions generating a profit, with an average return of +35.06% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GMED Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GMED has received 20 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the past 3 months is 97.64.

Each month's total comprises the sum of three months' worth of ratings.

GMED Financial Forecast

GMED Earnings Forecast

Next quarter’s earnings estimate for GMED is $1.08 with a range of $0.92 to $1.12. The previous quarter’s EPS was $1.18. GMED beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.

GMED Sales Forecast

Next quarter’s sales forecast for GMED is $778.31M with a range of $767.50M to $788.56M. The previous quarter’s sales results were $769.05M. GMED beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.

GMED Stock Forecast FAQ

What is GMED’s average 12-month price target, according to analysts?

Based on analyst ratings, Globus Medical’s 12-month average price target is 97.64.

What is GMED’s upside potential, based on the analysts’ average price target?

Globus Medical has 12.15% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GMED a Buy, Sell or Hold?

Globus Medical has a consensus rating of Moderate Buy which is based on 9 buy ratings, 4 hold ratings and 0 sell ratings.

What is Globus Medical’s price target?

The average price target for Globus Medical is 97.64. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $114.00 ,the lowest forecast is $64.00. The average price target represents 12.15% Increase from the current price of $87.06.

What do analysts say about Globus Medical?

Globus Medical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of GMED?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Globus Medical (GMED) Stock Forecast & Price Target

GMED Analyst Ratings

GMED Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Globus Medical

GMED Analyst Recommendation Trends

GMED Financial Forecast

GMED Earnings Forecast

GMED Sales Forecast

GMED Stock Forecast FAQ

Detailed List of Analyst Forecasts